REPLIGEN CORPORATION

(RGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 4 81510 41414 6438 345--
Enterprise Value (EV)1 4 5209 97214 4057 9097 7047 459
P/E ratio 210x173x118x63,2x49,6x41,4x
Yield ------
Capitalization / Revenue 17,8x28,4x21,8x10,6x9,35x7,77x
EV / Revenue 16,7x27,2x21,5x10,1x8,63x6,94x
EV / EBITDA 63,5x92,5x62,5x30,9x25,9x20,4x
Price to Book 4,29x6,86x8,67x4,47x4,05x3,63x
Nbr of stocks (in thousands) 52 05954 34455 28955 433--
Reference price (USD) 92,5192265151151151
Announcement Date 02/20/202002/24/202102/17/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 2703666717878921 074
EBITDA1 71,1108231256297366
Operating profit (EBIT)1 63,598,1215229266333
Operating Margin 23,5%26,8%32,1%29,1%29,8%31,0%
Pre-Tax Profit (EBT)1 26,259,2154182220283
Net income1 21,459,9128139179215
Net margin 7,92%16,4%19,1%17,6%20,1%20,0%
EPS2 0,441,112,242,383,033,63
Dividend per Share2 ------
Announcement Date 02/20/202002/24/202102/17/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 178187206190191199
EBITDA1 60,561,672,260,760,163,0
Operating profit (EBIT)1 57,055,967,453,652,555,2
Operating Margin 32,0%30,0%32,6%28,2%27,4%27,8%
Pre-Tax Profit (EBT)1 41,234,858,942,238,243,1
Net income1 33,529,147,032,129,029,4
Net margin 18,8%15,6%22,8%16,9%15,2%14,8%
EPS2 0,580,500,810,550,500,51
Dividend per Share ------
Announcement Date 10/28/202102/17/202204/27/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 296442238436642887
Leverage (Debt / EBITDA) -4,16x-4,10x-1,03x-1,70x-2,16x-2,42x
Free Cash Flow1 43,340,251,9117183221
ROE (Net Profit / Equities) 6,27%6,88%10,7%8,31%8,67%9,81%
Shareholders' equity1 3418711 2001 6692 0662 194
ROA (Net Profit / Asset) 4,83%5,39%8,23%6,65%7,04%8,18%
Assets1 4431 1111 5602 0862 5442 630
Book Value Per Share2 21,527,930,633,737,141,5
Cash Flow per Share2 1,26-3,863,524,125,02
Capex1 18,522,567,169,555,058,4
Capex / Sales 6,85%6,13%10,0%8,83%6,16%5,44%
Announcement Date 02/20/202002/24/202102/17/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 8 345 462 388
Net sales (USD) 670 534 000
Free-Float 93,2%
Free-Float capitalization (USD) 7 780 754 005
Avg. Exchange 20 sessions (USD) 113 243 800
Average Daily Capital Traded 1,36%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA